Medicine

New training initiative to focus on better communication skills

The American College of Veterinary Internal Medicine (ACVIM) and CareCredit are working together to help veterinarians develop advanced communication skills to improve the quality of care for pets and their families. Launching in 2020, the Advanced Clinician-Client Dynamics training initiative comprises workshops and courses to help veterinarians identify and address medical topics and concerns between clinicians, other veterinary team members, and clients early by recognizing pet owners' perspectives and goals. The goal of the three-year strategic partnership is to help participants use their knowledge to build greater trust with the pet owner, with the intended result of acceptance and follow through on medical recommendations, follow-up visits, and pursuit of advanced medical care for improved outcomes for the pet and family. By effectively connecting with team members and pet owners, veterinarians can work toward decreasing job-related stress and avoid burnout. "Traditionally, residency programs have focused on training for technical skills," says current ACVIM president-elect and incoming chief executive officer, Linda Fineman, DVM, DACVIM (oncology). "Along with a shifting demographic in our college, with many more ACVIM specialists working in private practice, there is greater recognition of the importance of professional skills in achieving better medical and business outcomes." The training initiative …

Elanco and Aratana Therapeutics finalize deal to merge

Elanco Animal Health has acquired Aratana Therapeutics. Structured as a stock-for-stock transaction, the deal was accepted by Aratana stockholders. "Aratana's strong position in the specialty market—with its current portfolio and pipeline—complements Elanco's field presence and capitalizes on new opportunities for key existing Elanco pet therapy brands," says Jeff Simmons, president and chief executive officer of Elanco. "This deal furthers Elanco's value-generating innovation, portfolio, and productivity (IPP) strategy, while continuing to bring great value to veterinarians and pet owners." Aratana produces Galliprant, a canine NSAID for osteoarthritis for which Elanco has had the exclusive rights to develop, manufacture, and commercialize since 2016. Aratana also contributes two additional products to Elanco's portfolio: Entyce, the only FDA-approved veterinary therapeutic to stimulate appetite in dogs, and Nocita, a long-acting local anesthetic that provides up to 72 hours of post-operative pain relief following certain surgeries in dogs and cats. Further, Aratana's research and development pipeline will contribute to Elanco's efforts to sustain the introduction of novel and innovative companion animal therapeutics. As a result of the acquisition, Elanco says it is forming a new commercial team dedicated to the veterinary specialty business into which the Aratana field force will transition. This specialty sales force will …